Chien-Chang Lee

Taiwan Ministry of Health and Welfare, Chief Information Officer

Speaker Bio

Chien-Chang Lee assumed the role of Chief Information Officer (CIO) for the Taiwan Ministry of Health and Welfare (MOHW) on January 16, 2024. Prior to this appointment, Chien-Chang held positions of distinction, including Professor of Emergency Medicine and Deputy Director of the Center of Intelligent Healthcare at National Taiwan University (NTU) Hospital. His journey in medicine began at NTU, where he completed his medical education and residency in emergency medicine before pursuing a doctorate in health data science at Harvard University, driven by his deep-seated commitment to clinical and population research.


 


As CIO, Chien-Chang oversees the information technology (IT) systems and security activities for a workforce exceeding 5,300 individuals. He spearheads the development and implementation of IT policies, manages critical projects, and strategically guides IT investments, aligning with the MOHW's mission to advance the health and well-being of the Taiwanese population. Chien-Chang also manages the department's substantial health IT budget.


 


Before his role as CIO, Chien-Chang served as the deputy director of the Center of Intelligent Healthcare at NTU since March 2020. In this capacity, he provided strategic direction for the integration of artificial intelligence (AI) into clinical settings, offering expertise in policy development, budgeting, innovation, and risk management.


 


Beyond his administrative roles, Chien-Chang's contributions to medicine are profound. As a Staff Physician in Emergency Medicine and Professor of Emergency Medicine, he provided critical care to emergency department patients and oversaw operations at a dynamic Biomedical Data Science lab. His research encompasses translational diagnostic medicine, big data epidemiology, computational biology, evidence-based medicine, and AI in clinical practice. Notably, his groundbreaking research on the association between fluoroquinolone antibiotics and aortic dissections and aneurysm ruptures prompted regulatory action by the United States Food and Drug Administration (FDA), leading to global revisions in antibiotic prescription guidelines.